When comparing electronic medical records (EMRs), figures like "No. 1 in adoption" or "ranked No. X in market share" jump out at you. If many clinics have chosen it, it must be safe—that is a natural way to think. But making an EMR's market share or track record the sole basis for your choice actually carries risks. This article organizes how to read share figures correctly, and the comparison criteria that a clinic director should truly examine.
How EMR market share is talked about
Even when we say "share," what it actually measures varies widely. The picture changes completely depending on whether it is a unit count including hospital-oriented systems, a figure limited to clinics without inpatient beds, or a ranking within the receipt-computer (rececon) market.
For example, ORCA (the Japan Medical Association Standard Receipt Software), known for being offered free of charge, is a representative product with a top-tier share in the rececon market (Japan Medical Association ORCA Management Organization). However, this is "the degree of penetration as a rececon," and it is not a figure that guarantees the latest usability, such as AI features or cloud support. Share only indicates the cumulative total from the past up to now; whether it is optimal for your clinic today is a separate question.
The pitfalls of choosing by share and track record alone
When you get pulled in by the size of the numbers, oversights like the following tend to occur.
- Overlooking fit with your specialty: Function requirements specific to a specialty—ophthalmology, orthopedics, psychiatry, and so on—do not show up in share figures.
- "More" may mean "older": The more a product has a long track record, the more its design philosophy may be dated and unable to fully support the cloud or AI.
- Support quality is unrelated to unit count: Even with a large number of installations, support for your region and clinic size is not necessarily generous.
- Sampling bias: Many expressions limit the tallying conditions, such as "No. 1 in a specific specialty," so simple comparison is impossible.
Share can serve as "reference information for narrowing down candidates," but if you make it the "deciding factor," you increase the risk of ending up with a product that does not fit your clinic.
Seven comparison criteria you should truly examine
Instead of share, we recommend evaluating the degree of fit for your clinic from the following perspectives.
| Comparison criterion | Points to check |
|---|---|
| Specialty fit | Whether it has functions suited to your specialty's operations and billing |
| Cost structure | The total and breakdown of initial cost, monthly fee, and maintenance fee |
| Deployment type | Cloud or on-premises, and whether it is extensible |
| Rececon | Integrated or separate, and the burden of billing and revision handling |
| Usability | Whether physicians and clerical staff actually find it easy to use |
| Support | The structure for handling failures, revisions, and migration assistance |
| Future readiness | The ongoing ability to keep up with AI, voice input, and regulatory revisions |
In particular, "usability" cannot be judged unless your clinic's actual staff try it in a demo or free trial. More than numbers, whether it fits into your clinic's daily care flow is decisively important.
From now on, "the power to evolve" over "track record"
Healthcare is changing ever faster year by year—regulatory revisions, DX, and the use of AI. Rather than a large past track record, whether a product can continue to respond to future change and keep evolving becomes the essential value for long-term use.
Pottech's "AI Karte" is an integrated receipt-computer EMR developed under an AI-native design philosophy. It creates SOAP-format charts by voice input from the conversation during a consultation, and its AI rezept check detects the risk of missed billing and returned claims in advance. Offered on the cloud with multi-device support, it complies with the 3-Ministry, 2-Guideline standards. Because it also keeps up with medical fee revisions on the system side, it suits clinics that want to choose based on "future growth potential" rather than "track-record numbers." The ability to perform management analytics end to end using the accumulated rezept and chart data is also a strength that conventional products lack.
In closing
An EMR's market share and track record are, at most, one piece of reference information for narrowing down candidates. Rather than being swayed by the size of the numbers, carefully determining—through multiple comparison criteria—whether a product fits your clinic's specialty, operations, and future vision leads to a choice you will not regret.
Through the provision of AI Karte, Pottech serves as the optimal business partner for clinics—supporting not only better working conditions for physicians, nurses, and medical clerical staff, but also helping clinics achieve to the fullest what they want to accomplish.
For details, please do not hesitate to contact us.